Proton Pump Inhibitors and Antifungals: How They Interfere with Absorption

When you're taking a proton pump inhibitor (PPI) like omeprazole for acid reflux and also need an antifungal like itraconazole for a serious fungal infection, something unexpected can happen: the antifungal may not work as well. This isn't a rare coincidence-it's a well-documented, clinically significant drug interaction that affects thousands of patients every year.

Why PPIs Reduce Antifungal Absorption

Proton pump inhibitors work by shutting down the acid-producing pumps in your stomach lining. That’s great for reducing heartburn, but it changes the environment where certain drugs need to dissolve before they can be absorbed. Azole antifungals like itraconazole, posaconazole, and voriconazole are weak bases. That means they need a low pH-around 3 or lower-to dissolve properly in your stomach. When a PPI raises your stomach pH to 4 or higher, these drugs don’t break down well. They sit there, mostly unchanged, and pass through your gut without being absorbed.

Studies show this isn’t theoretical. In one trial, patients taking omeprazole had up to a 60% drop in itraconazole levels in their blood. That’s not a small change-it’s enough to turn a therapeutic dose into an ineffective one. For someone fighting invasive aspergillosis or coccidioidomycosis, that drop could mean the difference between recovery and a life-threatening relapse.

Not All Antifungals Are Affected the Same

This interaction doesn’t apply to every antifungal. Fluconazole, for example, dissolves easily in water regardless of stomach pH. It doesn’t care if your stomach is acidic or neutral. Studies confirm its absorption stays steady even with PPIs. That’s why fluconazole is often the go-to choice when a patient needs both acid suppression and antifungal treatment.

But for others, the difference is stark:

• Itraconazole capsules: Absorption drops by 50-60% with PPIs. This is the most affected form.
• Itraconazole solution: Only 10-15% reduction. The liquid form is pre-dissolved, so it doesn’t rely on stomach acid.
• Voriconazole: Around 22-35% drop. Sensitive, but less than itraconazole.
• Posaconazole delayed-release tablets: 40% lower exposure with PPIs. The suspension form is less impacted.

The key takeaway? Formulation matters. A pill isn’t the same as a liquid. Switching from capsules to solution can make a measurable difference in treatment success.

PPIs vs. Other Acid Reducers

Not all drugs that reduce stomach acid are equal. H2 blockers like famotidine or ranitidine also raise pH-but not as much, and not for as long. PPIs can keep your stomach pH elevated for 12 to 24 hours. H2 blockers last 4 to 10 hours. That’s why switching from omeprazole to famotidine can restore itraconazole levels back to therapeutic range.

One study showed omeprazole cut itraconazole’s blood levels by 57%. Famotidine? Only 41%. That’s a big gap. And antacids? They work fast but only last minutes. If you take them 2 hours before or after your antifungal, the impact is minimal. Timing matters more than you think.

Real-World Consequences

This isn’t just lab data. In hospitals, pharmacists see the fallout daily. A 2022 survey of over 1,200 hospital pharmacists found 68% encountered at least one case per month where a patient’s antifungal failed because of a PPI. One case involved a patient with chronic lung aspergillosis whose itraconazole levels were so low-0.3 mcg/mL-that the infection kept spreading. After switching from omeprazole to famotidine, levels jumped to 1.7 mcg/mL. The patient improved within weeks.

But here’s the catch: many patients on PPIs don’t even need them. Studies suggest up to 70% of long-term PPI users have no clear medical indication. Yet, they’re still on them. When an antifungal is added, the interaction isn’t always caught. Medicare data shows nearly 39% of patients prescribed itraconazole capsules also got a PPI in the same month. For the liquid form? Only 12%. That gap suggests awareness is growing-but far from universal.

What to Do When Both Are Needed

If you’re prescribed both a PPI and an azole antifungal, here’s what works:

1. Switch to itraconazole solution if possible. It’s less affected by pH changes.
2. Use famotidine instead of a PPI. Take it 10 hours after the antifungal to minimize interference.
3. Separate doses by at least 2 hours. Take the antifungal first, then the PPI later.
4. For posaconazole tablets, take them with a glass of cola or orange juice. The acidity helps dissolve the drug.
5. Monitor drug levels. For itraconazole, aim for 0.5-1.0 mcg/mL in blood. If levels are low, adjust the regimen.

Pharmacists who intervene directly-checking prescriptions, educating staff, adjusting timing-see 82% adherence to these strategies. Without that oversight, mistakes happen. And in fungal infections, mistakes can be fatal.

The Surprising Twist: Synergism in the Lab

Here’s where things get fascinating. While PPIs reduce antifungal absorption in the body, lab studies show something odd: when you mix omeprazole and itraconazole together in a petri dish, they work better against resistant fungi. One 2025 study found this combo killed 77.6% of azole-resistant Aspergillus strains. That’s not a glitch-it’s a potential new treatment strategy.

The National Institutes of Health is already testing low-dose omeprazole with subtherapeutic itraconazole in early clinical trials for patients with resistant aspergillosis. If this pans out, we might one day use PPIs not as a problem to avoid-but as a tool to enhance antifungal power.

New Formulations Are Changing the Game

In 2023, the FDA approved a new version of itraconazole called Tolsura. Unlike traditional capsules, Tolsura is designed to absorb regardless of stomach pH. Studies show it only drops 8% in levels when taken with a PPI-compared to 50% for older capsules. That’s a game-changer. It means patients who need acid suppression won’t have to choose between their stomach and their infection.

What’s Next?

Guidelines from the Infectious Diseases Society of America and the American Gastroenterological Association are being updated in late 2024. They’ll have to balance two truths: PPIs can sabotage antifungals, but stopping them in high-risk patients can cause dangerous bleeding. There’s no one-size-fits-all answer. It depends on the patient, the infection, the drug form, and the alternatives.

For now, the rule is simple: if you’re on a PPI and need an azole antifungal, don’t assume it’s safe. Talk to your pharmacist. Check the formulation. Consider alternatives. Monitor levels. And remember-what looks like a routine prescription can hide a dangerous interaction.